MDGL NASDAQ
Madrigal Pharmaceuticals, Inc.
1W: -4.9%
1M: -2.9%
3M: +18.1%
YTD: -13.5%
1Y: +75.4%
3Y: +75.8%
5Y: +281.3%
$517.26
+3.67 (+0.71%)
Weekly Expected Move ±6.1%
$460
$492
$524
$555
$587
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1B
Revenue
+256.8% YoY
$-309M
Net Income
+21.0% YoY
$-272M
Free Cash Flow
+32.1% YoY
91.4%
Gross Margin
-29.8%
Op. Margin
-30.3%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-45.6%
ROA-26.9%
ROIC934.3%
Valuation
P/E-48.5
P/B27.6
EV/EBITDA-50.6
Leverage
Debt/Equity0.59
Current Ratio4.01
Interest Cov.-10.8x
Quality Scores
Piotroski F4/9
Altman Z12.59
Beneish M-1.15